Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-185-9 | CAS number: 12125-01-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
As ammonium fluoride decomposes in an aqueous environment into ammonium and fluoride ions, basic toxicokinetics of these two ions have been studied.
Ammonium
Plodikova and Cihak published a report in 2010 assessing the toxicokinetic behaviour of ammonium chloride using data from toxicological databases and experimental data of unpublished toxicological tests.
They found that after oral application ammonium chloride enters readily the body as a result of absorption by the gastrointestinal (GI) tract. After absorption by the GI tract, the test substance is utlized in the liver to form amino acids and proteins. The main target for toxicity are the kidneys.
When ammonium ions are converted to urea, liberated hydrogen ion reacts with bicarbonate ion to form water and carbon dioxide. The chloride ion displaces the bicarbonate ion. Chloride is loaded into the kidneys. The increased chloride concentration in the extracellular fluid produces an increased load to the renal tubules.
Increased excretion of electrolytes and water causes loss of extracellular fluid and promotes the mobilisation of edema fluid.
Furthermore, the test substance induces metabolic acidosis (shown by decreased plasma- and urinary-pH) and feeding of high level of the test substance causes decreased appetite, growth retardation, increased water consumption and increased urinary volume. Several studies with rats recorded increased kidney weight, renal hypertrophy with new cell formation (increase in total DNA and total RNA) and enlargement of existing cells.
For the following parameters an increase was also recorded: urinary ammonium, urea, sodium, plasma chloride, BUN, plasma proteins, urinary calcium, phosphate excretion, total erythrocytes and haemoglobin and haematocrit concentration.
Chronic stimulation of adrenal cortex by NH4+induced acidosis caused hypertrophy of adrenal zona glomerulosa.
Human incidental exposure following oral administration showed that ammonium chloride is rapidly absorbed from the gastrointestinal tract and complete absorption occurs within 3 to 6 hours. In healthy persons absorption of ammonium chloride given by mouth was practically complete. Only 1 to 3% of the dose was recovered in the faeces. Substantial first pass metabolism occurs in the liver.
Fluoride
A comparative study (Whitford et al., 1991) of fluoride pharmacokinetics in five species (dog, cat, rat, rabbit and hamster) determined that there are major quantitative differences in the metabolic handling of fluoride among the five species evaluated, and that plasma, renal and extra-renal (calcified tissue) values of the young adult dog, when factored for body weight, resemble those of a young adult human most closely. The 5-minute plasma fluoride concentrations were ordered as follows: dog > rabbit > rat > hamster > cat (concentrations were 110.8 +/- 14.3, 91.3 +/- 3.1, 78.4 +/- 5.3, 69.1 +/- 4.9 and 52.2 +/- 4.8 µmol/L respectively). In terms of body weight, the plasma clearances were highest in the hamster, rat, and cat (8.60, 7.34 and 7.24 mL/min/kg respectively), intermediate in the rabbit (5.80 mL/min/kg), and lowest in the dog (3.50 mL/min/kg). This result indicates that the hamster, rat and cat cleared fluoride from their extracellular fluids more than 2 times faster than the dog. The plasma clearance of fluoride in the rabbit was 66% faster than for the dog.
In another study (Susheela et al., 1982), rabbits were administered daily oral doses of 10 mg sodium fluoride/kg body weight by gavage for various periods of time and then levels of fluoride in serum, urine, non-calcified tissues, calcified tissues, erythrocyte membrane and hemolysate were estimated at different time intervals for the purpose of understanding how much fluoride was deposited, how much was excreted and what quantity of fluoride was in circulation. Following sodium fluoride ingestion, the circulating level of fluoride was enhanced. The increase in fluoride content was proportionate to the duration of sodium fluoride administration, at least up to 10 months. Urinary fluoride content data revealed that, due to sodium fluoride ingestion, the amount of excreted fluoride increased up to 30 days. Thereafter, for unknown reasons, fluoride excretion gradually diminished towards normal limits. Cortical and cancellous bone differed significantly in their fluoride content. Cancellous bone, upon sodium fluoride administration, showed greater affinity for fluoride uptake, possibly due to its greater surface area exposed. Fluoride content data of non-calcified tissues showed that less fluoride was taken up when compared to calcified tissue. However, in non-calcified tissues it was evident that different organ tissues varied in their affinity for fluoride and in their fluoride content. Upon sodium fluoride administration, all soft tissues investigated, including the erythrocyte membrane and hemolysate, showed enhanced fluoride content.
In an earlier study, Zipkin and Likins (1957) investigated the absorption of various fluorine compounds from the gastrointestinal tract of the rat. Sodium fluoride, as well as sodium fluorosilicate (Na2SiF6), sodium fluorophosphate (Na2PO3F) and stannous fluoride (SnF2) were absorbed through the gastrointestinal tract of the rat to the same extent (mean 48.4 +/- 1.6%), whereas potassium hexafluorophosphate (KPF6), tetraethylammonium hexafluorophosphate (EtNPF6) and potassium fluoroborate (KBF4) were absorbed to a significantly greater degree (73.6 +/- 2.0%). The results suggest that the difference in absorption rate between the two groups of fluorine compounds is related to their dissimilarity in electronic structure. In compounds with lower rates of absorption, fluorine is electrovalently bound and is present as the fluoride ion, whereas in compounds with greater rates of fluorine absorption, fluorine is covalently bound.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.